Compare ACIU & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACIU | LMNR |
|---|---|---|
| Founded | 2003 | 1893 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.7M | 218.5M |
| IPO Year | 2015 | 2005 |
| Metric | ACIU | LMNR |
|---|---|---|
| Price | $2.33 | $10.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $8.60 | ★ $20.83 |
| AVG Volume (30 Days) | ★ 193.5K | 128.2K |
| Earning Date | 11-04-2026 | 12-22-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $159,723,000.00 |
| Revenue This Year | $422.39 | N/A |
| Revenue Next Year | $377.85 | $17.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.02 | $10.05 |
| 52 Week High | $3.90 | $15.43 |
| Indicator | ACIU | LMNR |
|---|---|---|
| Relative Strength Index (RSI) | 48.00 | 43.13 |
| Support Level | $2.09 | N/A |
| Resistance Level | $2.47 | $13.71 |
| Average True Range (ATR) | 0.16 | 0.47 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 60.40 | 48.11 |
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.